Centogene N.V. (CNTGF)

OTCMKTS · Delayed Price · Currency is USD
0.0560
0.00 (0.00%)
Jul 31, 2025, 4:00 PM EDT
Market Cap1.89M
Revenue (ttm)53.65M
Net Income (ttm)-39.27M
Shares Out29.82M
EPS (ttm)-1.40
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume40
Average Volume651
Open0.0560
Previous Close0.0560
Day's Range0.0560 - 0.0560
52-Week Range0.0100 - 0.7050
Beta-0.11
RSI41.16
Earnings DateSep 5, 2025

About HashiCorp

Centogene N.V., together with its subsidiaries, provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific. The company offers data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It provides CENTOGENE MOx 2.0, a single-step multiomic solution that combines DNA sequencing, biochemical testing, and RNA sequencing; CentoCloud, a cloud-based Software as a Service platform, which enables laboratories to analyze, i... [Read more]

Sector Healthcare
Founded 2006
Employees 384
Stock Exchange OTCMKTS
Ticker Symbol CNTGF
Full Company Profile

Financial Performance

In 2023, Centogene's revenue was 48.54 million, an increase of 2.24% compared to the previous year's 47.47 million. Losses were -35.53 million, 11.6% more than in 2022.

Financial Statements

News

There is no news available yet.